Global Parkinson's Disease (PD) Drugs Market Research Report 2025(Status and Outlook)

March 2025 | 244 pages | ID: G9F12824B2F0EN
Bosson Research

Abstracts

Report Overview

Most people with Parkinson's disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement.

This report provides a deep insight into the global Parkinson's Disease (PD) Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Parkinson's Disease (PD) Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Parkinson's Disease (PD) Drugs market in any manner.

Global Parkinson's Disease (PD) Drugs Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Boehringer Ingelheim

GlaxoSmithKline

Novartis

Teva Pharmaceutical Industries

AbbVie

Abital Pharma

Addex Therapeutics

Biogen

Eisai

Eli Lilly

F. Hoffmann-La Roche

H. Lundbeck

Impax Laboratories

Kyowa Hakko Kirin

Otsuka Pharmaceutical

Pfizer

Market Segmentation (by Type)

Dopamine Agonist

Monoamine Oxidase Inhibitors

Acetylcholinesterase Inhibitors

Glutamate Inhibitors

Market Segmentation (by Application)

Hospital

Family

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Parkinson's Disease (PD) Drugs Market
• Overview of the regional outlook of the Parkinson's Disease (PD) Drugs Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Parkinson's Disease (PD) Drugs Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Parkinson's Disease (PD) Drugs
1.2 Key Market Segments
  1.2.1 Parkinson's Disease (PD) Drugs Segment by Type
  1.2.2 Parkinson's Disease (PD) Drugs Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 GLOBAL PARKINSON'S DISEASE (PD) DRUGS MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Parkinson's Disease (PD) Drugs Market Size (M USD) Estimates and Forecasts (2020-2033)
  2.1.2 Global Parkinson's Disease (PD) Drugs Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 GLOBAL PARKINSON'S DISEASE (PD) DRUGS MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Parkinson's Disease (PD) Drugs Product Life Cycle
3.3 Global Parkinson's Disease (PD) Drugs Sales by Manufacturers (2020-2025)
3.4 Global Parkinson's Disease (PD) Drugs Revenue Market Share by Manufacturers (2020-2025)
3.5 Parkinson's Disease (PD) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Parkinson's Disease (PD) Drugs Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Parkinson's Disease (PD) Drugs Manufacturing Sites, Area Served, Product Type
3.8 Parkinson's Disease (PD) Drugs Market Competitive Situation and Trends
  3.8.1 Parkinson's Disease (PD) Drugs Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Parkinson's Disease (PD) Drugs Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 PARKINSON'S DISEASE (PD) DRUGS INDUSTRY CHAIN ANALYSIS

4.1 Parkinson's Disease (PD) Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF PARKINSON'S DISEASE (PD) DRUGS MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Parkinson's Disease (PD) Drugs Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 Global Trade Frictions and Their Impacts to Parkinson's Disease (PD) Drugs Market
5.7 ESG Ratings of Leading Companies

6 GLOBAL PARKINSON'S DISEASE (PD) DRUGS MARKET BY REGION

6.1 Global Parkinson's Disease (PD) Drugs Market Size by Region
  6.1.1 Global Parkinson's Disease (PD) Drugs Market Size by Region
  6.1.2 Global Parkinson's Disease (PD) Drugs Market Size Market Share by Region
6.2 Global Parkinson's Disease (PD) Drugs Sales by Region
  6.2.1 Global Parkinson's Disease (PD) Drugs Sales by Region
  6.2.2 Global Parkinson's Disease (PD) Drugs Sales Market Share by Region

7 NORTH AMERICA MARKET OVERVIEW

7.1 North America Parkinson's Disease (PD) Drugs Market Size by Country
  7.1.1 USA Market Overview
  7.1.2 Canada Market Overview
  7.1.3 Mexico Market Overview
7.2 North America Parkinson's Disease (PD) Drugs Market Size by Type
7.3 North America Parkinson's Disease (PD) Drugs Market Size by Application

8 EUROPE MARKET OVERVIEW

8.1 Europe Parkinson's Disease (PD) Drugs Market Size by Country
  8.1.1 Germany Market Overview
  8.1.2 France Market Overview
  8.1.3 U.K. Market Overview
  8.1.4 Italy Market Overview
  8.1.5 Spain Market Overview
8.2 Europe Parkinson's Disease (PD) Drugs Market Size by Type
8.3 Europe Parkinson's Disease (PD) Drugs Market Size by Application

9 ASIA-PACIFIC MARKET OVERVIEW

9.1 Asia-Pacific Parkinson's Disease (PD) Drugs Market Size by Country
  9.1.1 China Market Overview
  9.1.2 Japan Market Overview
  9.1.3 South Korea Market Overview
  9.1.4 India Market Overview
  9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Parkinson's Disease (PD) Drugs Market Size by Type
9.3 Asia-Pacific Parkinson's Disease (PD) Drugs Market Size by Application

10 SOUTH AMERICA MARKET OVERVIEW

10.1 South America Parkinson's Disease (PD) Drugs Market Size by Country
  10.1.1 Brazil Market Overview
  10.1.2 Argentina Market Overview
  10.1.3 Columbia Market Overview
10.2 South America Parkinson's Disease (PD) Drugs Market Size by Type
10.3 South America Parkinson's Disease (PD) Drugs Market Size by Application

11 MIDDLE EAST AND AFRICA MARKET OVERVIEW

11.1 Middle East and Africa Parkinson's Disease (PD) Drugs Market Size by Country
  11.1.1 Saudi Arabia Market Overview
  11.1.2 UAE Market Overview
  11.1.3 Egypt Market Overview
  11.1.4 Nigeria Market Overview
  11.1.5 South Africa Market Overview
11.2 Middle East and Africa Parkinson's Disease (PD) Drugs Market Size by Type
11.3 Middle East and Africa Parkinson's Disease (PD) Drugs Market Size by Application

12 PARKINSON'S DISEASE (PD) DRUGS MARKET PRODUCTION BY REGION

12.1 Global Production of Parkinson's Disease (PD) Drugs by Region(2020-2025)
12.2 Global Parkinson's Disease (PD) Drugs Revenue Market Share by Region (2020-2025)
12.3 Global Parkinson's Disease (PD) Drugs Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Parkinson's Disease (PD) Drugs Production
  12.4.1 North America Parkinson's Disease (PD) Drugs Production Growth Rate (2020-2025)
  12.4.2 North America Parkinson's Disease (PD) Drugs Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Parkinson's Disease (PD) Drugs Production
  12.5.1 Europe Parkinson's Disease (PD) Drugs Production Growth Rate (2020-2025)
  12.5.2 Europe Parkinson's Disease (PD) Drugs Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Parkinson's Disease (PD) Drugs Production (2020-2025)
  12.6.1 Japan Parkinson's Disease (PD) Drugs Production Growth Rate (2020-2025)
  12.6.2 Japan Parkinson's Disease (PD) Drugs Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Parkinson's Disease (PD) Drugs Production (2020-2025)
  12.7.1 China Parkinson's Disease (PD) Drugs Production Growth Rate (2020-2025)
  12.7.2 China Parkinson's Disease (PD) Drugs Production, Revenue, Price and Gross Margin (2020-2025)

13 PARKINSON'S DISEASE (PD) DRUGS MARKET SEGMENTATION BY TYPE

13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Parkinson's Disease (PD) Drugs Sales Market Share by Type (2020-2033)
13.3 Global Parkinson's Disease (PD) Drugs Market Size Market Share by Type (2020-2033)
13.4 Global Parkinson's Disease (PD) Drugs Price by Type (2020-2033)

14 PARKINSON'S DISEASE (PD) DRUGS MARKET SEGMENTATION BY APPLICATION

14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Parkinson's Disease (PD) Drugs Market Sales by Application (2020-2033)
14.3 Global Parkinson's Disease (PD) Drugs Market Size (M USD) by Application (2020-2033)
14.4 Global Parkinson's Disease (PD) Drugs Sales Growth Rate by Application (2020-2033)

15 KEY COMPANIES PROFILE

15.1 Boehringer Ingelheim
  15.1.1 Boehringer Ingelheim Basic Information
  15.1.2 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Product Overview
  15.1.3 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Product Market Performance
  15.1.4 Boehringer Ingelheim Business Overview
  15.1.5 Boehringer Ingelheim SWOT Analysis
  15.1.6 Boehringer Ingelheim Recent Developments
15.2 GlaxoSmithKline
  15.2.1 GlaxoSmithKline Basic Information
  15.2.2 GlaxoSmithKline Parkinson's Disease (PD) Drugs Product Overview
  15.2.3 GlaxoSmithKline Parkinson's Disease (PD) Drugs Product Market Performance
  15.2.4 GlaxoSmithKline Business Overview
  15.2.5 GlaxoSmithKline SWOT Analysis
  15.2.6 GlaxoSmithKline Recent Developments
15.3 Novartis
  15.3.1 Novartis Basic Information
  15.3.2 Novartis Parkinson's Disease (PD) Drugs Product Overview
  15.3.3 Novartis Parkinson's Disease (PD) Drugs Product Market Performance
  15.3.4 Novartis Business Overview
  15.3.5 Novartis SWOT Analysis
  15.3.6 Novartis Recent Developments
15.4 Teva Pharmaceutical Industries
  15.4.1 Teva Pharmaceutical Industries Basic Information
  15.4.2 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Product Overview
  15.4.3 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Product Market Performance
  15.4.4 Teva Pharmaceutical Industries Business Overview
  15.4.5 Teva Pharmaceutical Industries Recent Developments
15.5 AbbVie
  15.5.1 AbbVie Basic Information
  15.5.2 AbbVie Parkinson's Disease (PD) Drugs Product Overview
  15.5.3 AbbVie Parkinson's Disease (PD) Drugs Product Market Performance
  15.5.4 AbbVie Business Overview
  15.5.5 AbbVie Recent Developments
15.6 Abital Pharma
  15.6.1 Abital Pharma Basic Information
  15.6.2 Abital Pharma Parkinson's Disease (PD) Drugs Product Overview
  15.6.3 Abital Pharma Parkinson's Disease (PD) Drugs Product Market Performance
  15.6.4 Abital Pharma Business Overview
  15.6.5 Abital Pharma Recent Developments
15.7 Addex Therapeutics
  15.7.1 Addex Therapeutics Basic Information
  15.7.2 Addex Therapeutics Parkinson's Disease (PD) Drugs Product Overview
  15.7.3 Addex Therapeutics Parkinson's Disease (PD) Drugs Product Market Performance
  15.7.4 Addex Therapeutics Business Overview
  15.7.5 Addex Therapeutics Recent Developments
15.8 Biogen
  15.8.1 Biogen Basic Information
  15.8.2 Biogen Parkinson's Disease (PD) Drugs Product Overview
  15.8.3 Biogen Parkinson's Disease (PD) Drugs Product Market Performance
  15.8.4 Biogen Business Overview
  15.8.5 Biogen Recent Developments
15.9 Eisai
  15.9.1 Eisai Basic Information
  15.9.2 Eisai Parkinson's Disease (PD) Drugs Product Overview
  15.9.3 Eisai Parkinson's Disease (PD) Drugs Product Market Performance
  15.9.4 Eisai Business Overview
  15.9.5 Eisai Recent Developments
15.10 Eli Lilly
  15.10.1 Eli Lilly Basic Information
  15.10.2 Eli Lilly Parkinson's Disease (PD) Drugs Product Overview
  15.10.3 Eli Lilly Parkinson's Disease (PD) Drugs Product Market Performance
  15.10.4 Eli Lilly Business Overview
  15.10.5 Eli Lilly Recent Developments
15.11 F. Hoffmann-La Roche
  15.11.1 F. Hoffmann-La Roche Basic Information
  15.11.2 F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Product Overview
  15.11.3 F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Product Market Performance
  15.11.4 F. Hoffmann-La Roche Business Overview
  15.11.5 F. Hoffmann-La Roche Recent Developments
15.12 H. Lundbeck
  15.12.1 H. Lundbeck Basic Information
  15.12.2 H. Lundbeck Parkinson's Disease (PD) Drugs Product Overview
  15.12.3 H. Lundbeck Parkinson's Disease (PD) Drugs Product Market Performance
  15.12.4 H. Lundbeck Business Overview
  15.12.5 H. Lundbeck Recent Developments
15.13 Impax Laboratories
  15.13.1 Impax Laboratories Basic Information
  15.13.2 Impax Laboratories Parkinson's Disease (PD) Drugs Product Overview
  15.13.3 Impax Laboratories Parkinson's Disease (PD) Drugs Product Market Performance
  15.13.4 Impax Laboratories Business Overview
  15.13.5 Impax Laboratories Recent Developments
15.14 Kyowa Hakko Kirin
  15.14.1 Kyowa Hakko Kirin Basic Information
  15.14.2 Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Product Overview
  15.14.3 Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Product Market Performance
  15.14.4 Kyowa Hakko Kirin Business Overview
  15.14.5 Kyowa Hakko Kirin Recent Developments
15.15 Otsuka Pharmaceutical
  15.15.1 Otsuka Pharmaceutical Basic Information
  15.15.2 Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Product Overview
  15.15.3 Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Product Market Performance
  15.15.4 Otsuka Pharmaceutical Business Overview
  15.15.5 Otsuka Pharmaceutical Recent Developments
15.16 Pfizer
  15.16.1 Pfizer Basic Information
  15.16.2 Pfizer Parkinson's Disease (PD) Drugs Product Overview
  15.16.3 Pfizer Parkinson's Disease (PD) Drugs Product Market Performance
  15.16.4 Pfizer Business Overview
  15.16.5 Pfizer Recent Developments

16 CONCLUSION AND KEY FINDINGS
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Parkinson's Disease (PD) Drugs Market Size by Type (M USD)
Table 4. Global Parkinson's Disease (PD) Drugs Market Size by Application (M USD)
Table 5. Parkinson's Disease (PD) Drugs Market Size Comparison by Region (M USD)
Table 6. Global Parkinson's Disease (PD) Drugs Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Parkinson's Disease (PD) Drugs Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Parkinson's Disease (PD) Drugs Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Parkinson's Disease (PD) Drugs Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson's Disease (PD) Drugs as of 2024)
Table 11. Global Market Parkinson's Disease (PD) Drugs Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 12. Manufacturers Parkinson's Disease (PD) Drugs Manufacturing Sites and Area Served
Table 13. Manufacturers Parkinson's Disease (PD) Drugs Product Type
Table 14. Global Parkinson's Disease (PD) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Parkinson's Disease (PD) Drugs Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. Parkinson's Disease (PD) Drugs Market Size Comparison by Region (M USD)
Table 26. Global Parkinson's Disease (PD) Drugs Market Size by Region (2020-2033) & (M USD)
Table 27. Global Parkinson's Disease (PD) Drugs Market Size Market Share by Region (2020-2033)
Table 28. Global Parkinson's Disease (PD) Drugs Sales by Region (2020-2033) & (K MT)
Table 29. Global Parkinson's Disease (PD) Drugs Sales Market Share by Region (2020-2033)
Table 30. North America Parkinson's Disease (PD) Drugs Market Size by Country (2020-2033) & (M USD)
Table 31. North America Parkinson's Disease (PD) Drugs Sales by Country (2020-2033) & (K MT)
Table 32. North America Parkinson's Disease (PD) Drugs Sales by Type (K MT)
Table 33. North America Parkinson's Disease (PD) Drugs Market Size by Type (M USD)
Table 34. North America Parkinson's Disease (PD) Drugs Sales (K MT) by Type (2020-2033)
Table 35. North America Parkinson's Disease (PD) Drugs Market Size (M USD) by Type (2020-2033)
Table 36. North America Parkinson's Disease (PD) Drugs Sales by Application (K MT)
Table 37. North America Parkinson's Disease (PD) Drugs Market Size by Application (M USD)
Table 38. North America Parkinson's Disease (PD) Drugs Sales (K MT) by Application (2020-2033)
Table 39. North America Parkinson's Disease (PD) Drugs Market Size (M USD) by Application (2020-2033)
Table 40. Europe Parkinson's Disease (PD) Drugs Market Size by Country (2020-2033) & (M USD)
Table 41. Europe Parkinson's Disease (PD) Drugs Sales by Country (2020-2033) & (K MT)
Table 42. Europe Parkinson's Disease (PD) Drugs Sales by Type (K MT)
Table 43. Europe Parkinson's Disease (PD) Drugs Market Size by Type (M USD)
Table 44. Europe Parkinson's Disease (PD) Drugs Sales (K MT) by Type (2020-2033)
Table 45. Europe Parkinson's Disease (PD) Drugs Market Size (M USD) by Type (2020-2033)
Table 46. Europe Parkinson's Disease (PD) Drugs Sales by Application (K MT)
Table 47. Europe Parkinson's Disease (PD) Drugs Market Size by Application (M USD)
Table 48. Europe Parkinson's Disease (PD) Drugs Sales (K MT) by Application (2020-2033)
Table 49. Europe Parkinson's Disease (PD) Drugs Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific Parkinson's Disease (PD) Drugs Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific Parkinson's Disease (PD) Drugs Sales by Country (2020-2025) & (K MT)
Table 52. Asia-Pacific Parkinson's Disease (PD) Drugs Sales by Type (K MT)
Table 53. Asia-Pacific Parkinson's Disease (PD) Drugs Market Size by Type (M USD)
Table 54. Asia-Pacific Parkinson's Disease (PD) Drugs Sales (K MT) by Type (2020-2033)
Table 55. Asia-Pacific Parkinson's Disease (PD) Drugs Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific Parkinson's Disease (PD) Drugs Sales by Application (K MT)
Table 57. Asia-Pacific Parkinson's Disease (PD) Drugs Market Size by Application (M USD)
Table 58. Asia-Pacific Parkinson's Disease (PD) Drugs Sales (K MT) by Application (2020-2033)
Table 59. Asia-Pacific Parkinson's Disease (PD) Drugs Market Size (M USD) by Application (2020-2025)
Table 60. South America Parkinson's Disease (PD) Drugs Market Size by Country (2020-2033) & (M USD)
Table 61. South America Parkinson's Disease (PD) Drugs Sales by Country (2020-2033) & (K MT)
Table 62. South America Parkinson's Disease (PD) Drugs Sales by Type (K MT)
Table 63. South America Parkinson's Disease (PD) Drugs Market Size by Type (M USD)
Table 64. South America Parkinson's Disease (PD) Drugs Sales (K MT) by Type (2020-2033)
Table 65. South America Parkinson's Disease (PD) Drugs Market Size (M USD) by Type (2020-2033)
Table 66. South America Parkinson's Disease (PD) Drugs Sales by Application (K MT)
Table 67. South America Parkinson's Disease (PD) Drugs Market Size by Application (M USD)
Table 68. South America Parkinson's Disease (PD) Drugs Sales (K MT) by Application (2020-2033)
Table 69. South America Parkinson's Disease (PD) Drugs Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa Parkinson's Disease (PD) Drugs Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa Parkinson's Disease (PD) Drugs Sales by Country (2020-2033) & (K MT)
Table 72. Middle East and Africa Parkinson's Disease (PD) Drugs Sales by Type (K MT)
Table 73. Middle East and Africa Parkinson's Disease (PD) Drugs Market Size by Type (M USD)
Table 74. Middle East and Africa Parkinson's Disease (PD) Drugs Sales (K MT) by Type (2020-2033)
Table 75. Middle East and Africa Parkinson's Disease (PD) Drugs Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa Parkinson's Disease (PD) Drugs Sales by Application (K MT)
Table 77. Middle East and Africa Parkinson's Disease (PD) Drugs Market Size by Application (M USD)
Table 78. Middle East and Africa Parkinson's Disease (PD) Drugs Sales (K MT) by Application (2020-2033)
Table 79. Middle East and Africa Parkinson's Disease (PD) Drugs Market Size (M USD) by Application (2020-2033)
Table 80. Global Parkinson's Disease (PD) Drugs Production (K MT) by Region(2020-2025)
Table 81. Global Parkinson's Disease (PD) Drugs Revenue (US$ Million) by Region (2020-2025)
Table 82. Global Parkinson's Disease (PD) Drugs Revenue Market Share by Region (2020-2025)
Table 83. Global Parkinson's Disease (PD) Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 84. North America Parkinson's Disease (PD) Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Europe Parkinson's Disease (PD) Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Japan Parkinson's Disease (PD) Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 87. China Parkinson's Disease (PD) Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Global Parkinson's Disease (PD) Drugs Sales by Type (K MT)
Table 89. Global Parkinson's Disease (PD) Drugs Market Size by Type (M USD)
Table 90. Global Parkinson's Disease (PD) Drugs Sales (K MT) by Type (2020-2033)
Table 91. Global Parkinson's Disease (PD) Drugs Sales Market Share by Type (2020-2033)
Table 92. Global Parkinson's Disease (PD) Drugs Market Size (M USD) by Type (2020-2033)
Table 93. Global Parkinson's Disease (PD) Drugs Market Size Share by Type (2020-2033)
Table 94. Global Parkinson's Disease (PD) Drugs Sales (K MT) by Application
Table 95. Global Parkinson's Disease (PD) Drugs Market Size by Application(M USD)
Table 96. Global Parkinson's Disease (PD) Drugs Sales by Application (2020-2033) & (K MT)
Table 97. Global Parkinson's Disease (PD) Drugs Sales Market Share by Application (2020-2033)
Table 98. Global Parkinson's Disease (PD) Drugs Market Size by Application (2020-2033) & (M USD)
Table 99. Global Parkinson's Disease (PD) Drugs Market Share by Application (2020-2033)
Table 100. Global Parkinson's Disease (PD) Drugs Sales Growth Rate by Application (2020-2033)
Table 101. Boehringer Ingelheim Basic Information
Table 102. Boehringer Ingelheim Parkinson's Disease (PD) Drugs Product Overview
Table 103. Boehringer Ingelheim Parkinson's Disease (PD) Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 104. Boehringer Ingelheim Business Overview
Table 105. Boehringer Ingelheim SWOT Analysis
Table 106. Boehringer Ingelheim Recent Developments
Table 107. GlaxoSmithKline Basic Information
Table 108. GlaxoSmithKline Parkinson's Disease (PD) Drugs Product Overview
Table 109. GlaxoSmithKline Parkinson's Disease (PD) Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. GlaxoSmithKline Business Overview
Table 111. GlaxoSmithKline SWOT Analysis
Table 112. GlaxoSmithKline Recent Developments
Table 113. Novartis Basic Information
Table 114. Novartis Parkinson's Disease (PD) Drugs Product Overview
Table 115. Novartis Parkinson's Disease (PD) Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. Novartis Business Overview
Table 117. Novartis SWOT Analysis
Table 118. Novartis Recent Developments
Table 119. Teva Pharmaceutical Industries Basic Information
Table 120. Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Product Overview
Table 121. Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. Teva Pharmaceutical Industries Business Overview
Table 123. Teva Pharmaceutical Industries Recent Developments
Table 124. AbbVie Basic Information
Table 125. AbbVie Parkinson's Disease (PD) Drugs Product Overview
Table 126. AbbVie Parkinson's Disease (PD) Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 127. AbbVie Business Overview
Table 128. AbbVie Recent Developments
Table 129. Abital Pharma Basic Information
Table 130. Abital Pharma Parkinson's Disease (PD) Drugs Product Overview
Table 131. Abital Pharma Parkinson's Disease (PD) Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 132. Abital Pharma Business Overview
Table 133. Abital Pharma Recent Developments
Table 134. Addex Therapeutics Basic Information
Table 135. Addex Therapeutics Parkinson's Disease (PD) Drugs Product Overview
Table 136. Addex Therapeutics Parkinson's Disease (PD) Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 137. Addex Therapeutics Business Overview
Table 138. Addex Therapeutics Recent Developments
Table 139. Biogen Basic Information
Table 140. Biogen Parkinson's Disease (PD) Drugs Product Overview
Table 141. Biogen Parkinson's Disease (PD) Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 142. Biogen Business Overview
Table 143. Biogen Recent Developments
Table 144. Eisai Basic Information
Table 145. Eisai Parkinson's Disease (PD) Drugs Product Overview
Table 146. Eisai Parkinson's Disease (PD) Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 147. Eisai Business Overview
Table 148. Eisai Recent Developments
Table 149. Eli Lilly Basic Information
Table 150. Eli Lilly Parkinson's Disease (PD) Drugs Product Overview
Table 151. Eli Lilly Parkinson's Disease (PD) Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 152. Eli Lilly Business Overview
Table 153. Eli Lilly Recent Developments
Table 154. F. Hoffmann-La Roche Basic Information
Table 155. F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Product Overview
Table 156. F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 157. F. Hoffmann-La Roche Business Overview
Table 158. F. Hoffmann-La Roche Recent Developments
Table 159. H. Lundbeck Basic Information
Table 160. H. Lundbeck Parkinson's Disease (PD) Drugs Product Overview
Table 161. H. Lundbeck Parkinson's Disease (PD) Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 162. H. Lundbeck Business Overview
Table 163. H. Lundbeck Recent Developments
Table 164. Impax Laboratories Basic Information
Table 165. Impax Laboratories Parkinson's Disease (PD) Drugs Product Overview
Table 166. Impax Laboratories Parkinson's Disease (PD) Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 167. Impax Laboratories Business Overview
Table 168. Impax Laboratories Recent Developments
Table 169. Kyowa Hakko Kirin Basic Information
Table 170. Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Product Overview
Table 171. Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 172. Kyowa Hakko Kirin Business Overview
Table 173. Kyowa Hakko Kirin Recent Developments
Table 174. Otsuka Pharmaceutical Basic Information
Table 175. Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Product Overview
Table 176. Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 177. Otsuka Pharmaceutical Business Overview
Table 178. Otsuka Pharmaceutical Recent Developments
Table 179. Pfizer Basic Information
Table 180. Pfizer Parkinson's Disease (PD) Drugs Product Overview
Table 181. Pfizer Parkinson's Disease (PD) Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 182. Pfizer Business Overview
Table 183. Pfizer Recent Developments
List of Figures
Figure 1. Product Picture of Parkinson's Disease (PD) Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Parkinson's Disease (PD) Drugs Market Size (M USD), 2024-2033
Figure 5. Global Parkinson's Disease (PD) Drugs Market Size (M USD) (2020-2033)
Figure 6. Global Parkinson's Disease (PD) Drugs Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Parkinson's Disease (PD) Drugs Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Parkinson's Disease (PD) Drugs Product Life Cycle
Figure 13. Parkinson's Disease (PD) Drugs Sales Share by Manufacturers in 2024
Figure 14. Global Parkinson's Disease (PD) Drugs Revenue Share by Manufacturers in 2024
Figure 15. Parkinson's Disease (PD) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Parkinson's Disease (PD) Drugs Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Parkinson's Disease (PD) Drugs Revenue in 2024
Figure 18. Industry Chain Map of Parkinson's Disease (PD) Drugs
Figure 19. Global Parkinson's Disease (PD) Drugs Market PEST Analysis
Figure 20. Global Parkinson's Disease (PD) Drugs Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global Parkinson's Disease (PD) Drugs Market Size by Region
Figure 27. Global Parkinson's Disease (PD) Drugs Market Size Market Share by Region (2020-2033)
Figure 28. Global Parkinson's Disease (PD) Drugs Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2033) & (K MT)
Figure 31. North America Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America Parkinson's Disease (PD) Drugs Market Size (M USD) by Country
Figure 33. USA Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2033) & (K MT)
Figure 34. USA Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada Parkinson's Disease (PD) Drugs Sales (K MT) and Growth Rate (2020-2033)
Figure 36. Canada Parkinson's Disease (PD) Drugs Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico Parkinson's Disease (PD) Drugs Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico Parkinson's Disease (PD) Drugs Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America Parkinson's Disease (PD) Drugs Market Size (M USD)by Type
Figure 40. North America Parkinson's Disease (PD) Drugs Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2033) & (K MT)
Figure 43. Europe Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe Parkinson's Disease (PD) Drugs Market Size (M USD) by Country
Figure 45. Germany Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2033) & (K MT)
Figure 46. Germany Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2033) & (K MT)
Figure 48. France Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2033) & (K MT)
Figure 50. U.K. Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2033) & (K MT)
Figure 52. Italy Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2033) & (K MT)
Figure 54. Spain Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe Parkinson's Disease (PD) Drugs Market Size (M USD) by Type
Figure 56. Europe Parkinson's Disease (PD) Drugs Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2033) & (K MT)
Figure 59. Asia-Pacific Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific Parkinson's Disease (PD) Drugs Market Size (M USD) by Country
Figure 61. China Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. China Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Japan Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 66. South Korea Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 68. India Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 70. Southeast Asia Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific Parkinson's Disease (PD) Drugs Market Size (M USD) by Type
Figure 72. Asia-Pacific Parkinson's Disease (PD) Drugs Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2033) & (K MT)
Figure 75. South America Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America Parkinson's Disease (PD) Drugs Market Size (M USD) by Country
Figure 77. Brazil Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2033) & (K MT)
Figure 78. Brazil Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2033) & (K MT)
Figure 80. Argentina Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2033) & (K MT)
Figure 82. Columbia Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America Parkinson's Disease (PD) Drugs Market Size (M USD) by Type
Figure 84. South America Parkinson's Disease (PD) Drugs Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2033) & (K MT)
Figure 87. Middle East and Africa Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa Parkinson's Disease (PD) Drugs Market Size (M USD) by Country
Figure 89. Saudi Arabia Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2033) & (K MT)
Figure 90. Saudi Arabia Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2033) & (K MT)
Figure 92. UAE Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2033) & (K MT)
Figure 94. Egypt Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2033) & (K MT)
Figure 96. Nigeria Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2033) & (K MT)
Figure 98. South Africa Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa Parkinson's Disease (PD) Drugs Market Size (M USD) by Type
Figure 100. Middle East and Africa Parkinson's Disease (PD) Drugs Market Size (M USD) by Application
Figure 101. Global Parkinson's Disease (PD) Drugs Production Market Share by Region (2020-2025)
Figure 102. North America Parkinson's Disease (PD) Drugs Production (K MT) Growth Rate (2020-2025)
Figure 103. Europe Parkinson's Disease (PD) Drugs Production (K MT) Growth Rate (2020-2025)
Figure 104. Japan Parkinson's Disease (PD) Drugs Production (K MT) Growth Rate (2020-2025)
Figure 105. China Parkinson's Disease (PD) Drugs Production (K MT) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global Parkinson's Disease (PD) Drugs Market Size by Type (M USD)
Figure 108. Sales Market Share of Parkinson's Disease (PD) Drugs by Type (2020-2033)
Figure 109. Sales Market Share of Parkinson's Disease (PD) Drugs by Type in 2024
Figure 110. Market Size Share of Parkinson's Disease (PD) Drugs by Type (2020-2033)
Figure 111. Market Size Share of Parkinson's Disease (PD) Drugs by Type in 2024
Figure 112. Global Parkinson's Disease (PD) Drugs Price (USD/MT) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global Parkinson's Disease (PD) Drugs Market Size by Application(M USD)
Figure 115. Global Parkinson's Disease (PD) Drugs Market Share by Application
Figure 116. Global Parkinson's Disease (PD) Drugs Sales Market Share by Application (2020-2033)
Figure 117. Global Parkinson's Disease (PD) Drugs Sales Market Share by Application in 2024
Figure 118. Global Parkinson's Disease (PD) Drugs Market Share by Application (2020-2033)
Figure 119. Global Parkinson's Disease (PD) Drugs Market Share by Application in 2024
Figure 120. Global Parkinson's Disease (PD) Drugs Sales Growth Rate by Application (2020-2033)